Susceptibility to Pathological Gambling
The goal of this study is to assess the risk factors for the development of pathological gambling.
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
|Official Title:||Susceptibility to Pathological Gambling|
- Structured Clinical Interview for Pathological Gambling (SCI-PG) [ Time Frame: Up to 3 years ] [ Designated as safety issue: No ]
The SCI-PG is a validated and reliable scale assessing the presence of DSM-IV criteria for pathological gambling. The number of criteria met for PG is added for a total score and those meeting 5 or more criteria have DSM-IV pathological gambling.
Subjects are expected to be followed for the duration of the 3 year study.
Diagnostic criteria for pathological gambling every 3 months for the length of the study
|Study Start Date:||November 2008|
|Estimated Study Completion Date:||September 2015|
|Estimated Primary Completion Date:||September 2015 (Final data collection date for primary outcome measure)|
No Intervention: Control
Active Comparator: Mindfulness
Mindfulness activity and psychoeducation
Subjects receive mindfulness training
Other Name: Training
Active Comparator: Cognition
Cognitive training and psychoeducation
Subject receive cognitive training
Other Name: Training
This study will track up to 600 young adults (ages 18 to 29) for a two-year period, collecting variables such as gambling behavior, drug and alcohol use, psychiatry and medical history, family history, impulsivity, quality of life, self-esteem, and cognition. For some individuals who meet criteria as being impulsive, they will be randomized to receive an intervention to help reduce their impulsivity.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01528982
|Contact: Eric Leppink, BAfirstname.lastname@example.org|
|United States, Illinois|
|University of Chicago||Recruiting|
|Chicago, Illinois, United States, 60637|
|Contact: Jon E Grant, JD, MD, MPH 773-834-1325 email@example.com|
|Contact: Eric Leppink, BA 773-834-3778 firstname.lastname@example.org|
|Principal Investigator: Jon E Grant, JD, MD, MPH|
|Principal Investigator:||Jon E Grant, JD, MD, MPH||University of Chicago, Department of Psychiatry|